Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8259
|
pubmed:dateCreated |
1982-2-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1344-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6118738-Aluminum,
pubmed-meshheading:6118738-Apraxias,
pubmed-meshheading:6118738-Brain Diseases,
pubmed-meshheading:6118738-Deferoxamine,
pubmed-meshheading:6118738-Dysarthria,
pubmed-meshheading:6118738-Humans,
pubmed-meshheading:6118738-Male,
pubmed-meshheading:6118738-Renal Dialysis
|
pubmed:year |
1981
|
pubmed:articleTitle |
Treatment of early stages of dialysis encephalopathy by aluminium depletion.
|
pubmed:publicationType |
Letter,
Case Reports
|